Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2176 to 2190 of 7679 results

  1. Durvalumab for adjuvant treatment of hepatocellular carcinoma at high risk of recurrence after curative liver resection or ablation [ID6206]

    Awaiting development [GID-TA11161] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  2. High-dose aflibercept for treating wet age-related macular degeneration TS ID 10590

      Status ...

    Technology appraisal guidance
    Topic selection

  3. Aflibercept for untreated diabetic macular oedema TS ID 10621

      Status ...

    Technology appraisal guidance
    Topic selection

  4. Lymphatico-venous anastomosis for chronic lymphoedema

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  5. Sacituzumab govitecan for untreated PD-L1-negative triple-negative advanced breast cancer ID6433

    Awaiting development [GID-TA11489] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  6. Ruxolitinib for treating acute graft-versus-host disease after allogeneic stem cell transplant in people 28 days to 17 years [ID6410]

    Awaiting development [GID-TA11494] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  7. Retifanlimab with chemotherapy for previously untreated metastatic non-small-cell lung cancer ID 6436

    Awaiting development [GID-TA11532] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  8. Pembrolizumab for adjuvant treatment of hepatocellular carcinoma [ID3994]

    Awaiting development [GID-TA10895] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  9. Somapacitan for treating growth hormone deficiency in children [ID6178]

    In development [GID-TA11153] Expected publication date: TBC

    Technology appraisal guidance
    In development

  10. Liposomal bupivacaine for treating postoperative pain [ID3799]

    The topic was stopped after scoping, this means the topic will not proceed to a Technology Appraisal   ...

    Technology appraisal guidance
    Topic selection

  11. Suspected sepsis: recognition, diagnosis and early management

    In development [GID-NG10412] Expected publication date: 13 August 2025

    NICE guideline
    In development

  12. Olorofim for treating invasive fungal infections in people 16 years and over TS ID 11983

      Status ...

    Technology appraisal guidance
    Topic selection

  13. Cor-Knot for tying suture knots in valve surgery

      Status ...

    Medical technologies guidance
    Topic selection

  14. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation

      Status ...

    Medical technologies guidance
    Topic selection

  15. Cytokine adsorption technologies for treating respiratory failure in people with COVID-19

      Status ...

    Medical technologies guidance
    Topic selection